ACT Advisors’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

ACT Advisors’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,358	Closed	-$693	–	69
2024 Q4	$693	Buy	+13,358	New	+$3.08K	﹤0.01%	58

ACT Advisors's NVOS Position: Q1 2025 in Review

ACT Advisors sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q1 2025, closing a stake of 13,358 shares — an estimated $693 sold.

ACT Advisors first reported a position in NVOS in Q4 2024 and held it in 1 quarter. The position peaked at $693 in Q4 2024. 0 funds tracked by Wall St. Rank hold NVOS as of Q1 2025.

ACT Advisors reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
ACT Advisors sold 13,358 Novo Integrated Sciences, Inc. Common Stock shares in Q1 2025, an estimated $693.
ACT Advisors first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
ACT Advisors's Novo Integrated Sciences, Inc. Common Stock position peaked at $693 in Q4 2024.
0 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q1 2025.

Based on ACT Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.